Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
The SELECT trial extended this finding to people with obesity but without diabetes
That triple mechanism is what produced the headline-grabbing results from the Phase 2 NEJM trial, where the 12 mg dose group achieved an average 24.2% body weight reduction over 48 weeks
Doctors can legally prescribe CJC-1295 for performance optimization and hormone therapy
Intra- and interobserver variability was lower than 2.86% for all measures 11
The absence of validated predictive biomarkers limits precision medicine approaches, though companion diagnostics for TL1A and prognostic transcriptional signatures are under investigation
US$ 24.80
US$ 22.23
US$ 22.03
US$ 24.24
US$ 26.82
